Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Two phenotypically different types of skin leasion are associated with CARD14 mutations. Both of them belong to the psoriasis group.
| 1. |
Kint A et. al. () Pityriasis rubra pilaris, a familial condition. 
|
| 2. |
Giardina E et. al. (2006) PSORS2 markers are not associated with psoriatic arthritis in the Italian population.
|
| 3. |
Stuart P et. al. (2006) Analysis of RUNX1 binding site and RAPTOR polymorphisms in psoriasis: no evidence for association despite adequate power and evidence for linkage.
|
| 4. |
Capon F et. al. (2004) Genetic analysis of PSORS2 markers in a UK dataset supports the association between RAPTOR SNPs and familial psoriasis.
|
| 5. |
Speckman RA et. al. (2003) Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility.
|
| 6. |
Enlund F et al. (1999) Analysis of three suggested psoriasis susceptibility loci in a large Swedish set of families: confirmation of linkage to chromosome 6p (HLA region), and to 17q, but not to 4q.
|
| 7. |
Matthews D et. al. (1995) Confirmation of genetic heterogeneity in familial psoriasis.
|
| 8. |
Nair RP et. al. () Scanning chromosome 17 for psoriasis susceptibility: lack of evidence for a distal 17q locus.
|
| 9. |
Sehgal VN et. al. (2006) (Juvenile) Pityriasis rubra pilaris.
|
| 10. |
Sehgal VN et. al. () Familial pityriasis rubra pilaris (adult classic-I): a report of three cases in a single family.
|
| 11. |
Sehgal VN et. al. (2000) Pityriasis rubra pilaris (PRP): report of four cases.
|
| 12. |
Vanderhooft SL et. al. (1995) Familial pityriasis rubra pilaris.
|
| 13. |
None (1984) Pityriasis rubra pilaris. Etiologic considerations.
|
| 14. |
Parish LC et. al. (1969) Pityriasis rubra pilaris in Korea. Treatment with methotrexate.
|
| 15. |
Helms C et. al. (2003) A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.
|
| 16. |
None (1992) Pityriasis rubra pilaris: the problem of its classification.
|
| 17. |
Wang M et al. (2018) Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.
|
| 18. |
Fuchs-Telem D et. al. (2012) Familial pityriasis rubra pilaris is caused by mutations in CARD14.
|
| 19. |
Jordan CT et al. (2012) Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
|
| 20. |
Jordan CT et. al. (2012) PSORS2 is due to mutations in CARD14.
|
| 21. |
Yang CF et al. (2008) A promoter sequence variant of ZNF750 is linked with familial psoriasis.
|
| 22. |
Hwu WL et. al. (2005) Mapping of psoriasis to 17q terminus.
|
| 23. |
Gaide O et al. (2001) Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation.
|
| 24. |
Bertin J et al. (2001) CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B.
|
| 25. |
Tomfohrde J et. al. (1994) Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q.
|
| 26. |
Nair RP et al. (1997) Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan.
|
| 27. |
Krber A et. al. (2013) Mutations in IL36RN in patients with generalized pustular psoriasis.
|
 |
Copyright © 2005-2025 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944 Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits |
